An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

Growing demand for weight-loss solutions has catapulted pharmaceutical firms like Eli Lilly (LLY) and Novo Nordisk (NVO) into ...

As Amanda Phommachanh, a 45-year-old realtor in Manassas, Virginia, describes it, she was on track with Wegovy to meet her ...

Shares in Veru fell by nearly half following the news, despite positive results in preserving lean muscle mass.

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Allurion catapulted Friday after the company said it plans to test its weight-loss technology with an obesity drug.